6505-01-281-3558 Loperamide hydrochloride capsule
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 1
- Next due November 18, 2026
- Last price paid
- …
- Standard price
- $265.80 per BT
- DLA's catalog price, not a price paid
- Approved sources
- 2
- Awards on record
- 24
- 2013 to 2026
- DLA demand
- –
Identification
- Item name
- Loperamide hydrochloride capsule
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 22-JUN-88
- Unit
- BT
- NSN
- 6505-01-281-3558
- NIIN
- 01-281-3558
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and suppliers DLA has qualified for this item
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # |
|---|---|---|---|---|
| MYLAN PHARMACEUTICALS INC | 3KJG9 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC00378-2100-05 |
| TEVA PHARMACEUTICALS USA, INC. | 3V8D7 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC00093-0311-05 |
Source: DLA's approved-source file published with the RFQs. CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3004909260 (Medicaments primarily affect digest system nesoi)
- PINC
- 0048489
- Criticality (CRIT CD)
- X
- On FedMall
- Yes
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | BT | $209.10 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | BT | $209.10 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | BT | $209.10 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | BT | $265.80 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0314DIBBS only | 6505-01-281-3558 | Loperamide hydrochloride capsule | 2 | BT | $265.80 per BT | … | … | No set-aside | No | November 12, 2026 | November 18, 20265 days left |
| SPE2DP27T0169DIBBS only | 6505-01-281-3558 | Loperamide hydrochloride capsule | 1 | BT | $265.80 per BT | … | … | No set-aside | No | October 25, 2026 | November 2, 2026Closed |
| SPE2DP27T0005DIBBS only | 6505-01-281-3558 | Loperamide hydrochloride capsule | 2 | BT | $265.80 per BT | … | … | No set-aside | November 11, 2026First seen | October 7, 2026Closed |
→ These RFQs in the DIBBS list
“First seen”: an RFQ from DIBBS's file of all open RFQs, which gives no issue date. Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 90 days, production 120 days (210 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
24 award lines since 2013, 4 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 0AG09SZY HOLDINGS, LLC | 15 | May 4, 2026 |
| 3W8H0MR UNLIMITED, LLC | 6 | July 13, 2026 |
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 2 | September 27, 2017 |
| 6UV66MIDWEST PHARMACEUTICALS INC | 1 | June 7, 2022 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 5 | 2 |
| 2025 | 11 | 2 |
| 2024 | 1 | 1 |
| 2023 | 1 | 1 |
| 2022 | 4 | 2 |
| 2017 | 1 | 1 |
| 2013 | 1 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
23 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | SZY HOLDINGS, LLC | $9,952 | 15 |
| 2 | DMS PHARMACEUTICAL GROUP INC | $9,277 | 1 |
| 3 | MR UNLIMITED, LLC | $2,008 | 6 |
| 4 | MIDWEST PHARMACEUTICALS INC | $300 | 1 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2DP26P1007From the item's award history | July 13, 2026 | MR UNLIMITED, LLC | $137 |
| SPE2DP26P1008From the item's award history | July 13, 2026 | MR UNLIMITED, LLC | $137 |
| SPE2DP26V0686From the item's award history | May 4, 2026 | SZY HOLDINGS, LLC | $412 |
| SPE2DP26V0540From the item's award history | March 19, 2026 | SZY HOLDINGS, LLC | $1,099 |
| SPE2DP26V0510From the item's award history | March 11, 2026 | SZY HOLDINGS, LLC | $417 |
| SPE2DP26V0224From the item's award history | December 8, 2025 | MR UNLIMITED, LLC | $140 |
| SPE2DP26P0134From the item's award history | November 19, 2025 | SZY HOLDINGS, LLC | $843 |
| SPE2DP26P0131From the item's award history | November 12, 2025 | SZY HOLDINGS, LLC | $1,816 |
| SPE2DP25V3637From the item's award history | September 10, 2025 | SZY HOLDINGS, LLC | $709 |
| SPE2DP25V3158From the item's award history | July 30, 2025 | MR UNLIMITED, LLC | $431 |
| SPE2DP25V2882From the item's award history | July 10, 2025 | SZY HOLDINGS, LLC | $144 |
| SPE2DP25V2138From the item's award history | May 19, 2025 | SZY HOLDINGS, LLC | $144 |
| SPE2DP25V2096From the item's award history | May 15, 2025 | SZY HOLDINGS, LLC | $144 |
| SPE2DP25V2044From the item's award history | May 9, 2025 | SZY HOLDINGS, LLC | $1,425 |
| SPE2DP25V1692From the item's award history | April 8, 2025 | MR UNLIMITED, LLC | $725 |
| SPE2DP25V0919From the item's award history | February 5, 2025 | MR UNLIMITED, LLC | $438 |
| SPE2DP25V0348From the item's award history | November 19, 2024 | SZY HOLDINGS, LLC | $149 |
| SPE2DP24V0441From the item's award history | December 22, 2023 | SZY HOLDINGS, LLC | $584 |
| SPE2DP22V1456From the item's award history | July 14, 2022 | SZY HOLDINGS, LLC | $1,470 |
| SPE2DP22V1211From the item's award history | June 7, 2022 | MIDWEST PHARMACEUTICALS INC | $300 |
| SPE2DP22V1003From the item's award history | April 27, 2022 | SZY HOLDINGS, LLC | $300 |
| SPE2DP22V0866From the item's award history | March 30, 2022 | SZY HOLDINGS, LLC | $296 |
| SPE2DX15D9383/9656From the item's award history | September 27, 2017 | DMS PHARMACEUTICAL GROUP INC | $9,277 |
Showing 1 to 10 of 23 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.